BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 11712940)

  • 21. Aberration of FHIT gene is associated with increased tumor proliferation and decreased apoptosis-clinical evidence in lung and head and neck carcinomas.
    Pavelić K; Krizanac S; Cacev T; Hadzija MP; Radosević S; Crnić I; Levanat S; Kapitanović S
    Mol Med; 2001 Jul; 7(7):442-53. PubMed ID: 11683369
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Loss of FHIT expression in cervical carcinoma cell lines and primary tumors.
    Greenspan DL; Connolly DC; Wu R; Lei RY; Vogelstein JT; Kim YT; Mok JE; Muñoz N; Bosch FX; Shah K; Cho KR
    Cancer Res; 1997 Nov; 57(21):4692-8. PubMed ID: 9354423
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Down-regulation of fragile histidine triad expression in prostate carcinoma.
    Fouts RL; Sandusky GE; Zhang S; Eckert GJ; Koch MO; Ulbright TM; Eble JN; Cheng L
    Cancer; 2003 Mar; 97(6):1447-52. PubMed ID: 12627509
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunohistochemical expression of Fhit protein in Helicobacter pylori related chronic gastritis, gastric precancerous lesions and gastric carcinoma: correlation with conventional clinicopathologic parameters.
    Skopelitou AS; Mitselou A; Katsanos KH; Alexopoulou V; Tsianos EV
    Eur J Gastroenterol Hepatol; 2003 May; 15(5):515-23. PubMed ID: 12702909
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Fhit-ing role in the DNA damage checkpoint response.
    Ishii H; Wang Y; Huebner K
    Cell Cycle; 2007 May; 6(9):1044-8. PubMed ID: 17457056
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of FHIT in human cancer.
    Croce CM; Sozzi G; Huebner K
    J Clin Oncol; 1999 May; 17(5):1618-24. PubMed ID: 10334551
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The fragile histidine triad gene: a molecular link between cigarette smoking and cervical cancer.
    Holschneider CH; Baldwin RL; Tumber K; Aoyama C; Karlan BY
    Clin Cancer Res; 2005 Aug; 11(16):5756-63. PubMed ID: 16115913
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The fragile histidine triad/common chromosome fragile site 3B locus and repair-deficient cancers.
    Turner BC; Ottey M; Zimonjic DB; Potoczek M; Hauck WW; Pequignot E; Keck-Waggoner CL; Sevignani C; Aldaz CM; McCue PA; Palazzo J; Huebner K; Popescu NC
    Cancer Res; 2002 Jul; 62(14):4054-60. PubMed ID: 12124341
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Restoration of fragile histidine triad expression restores Chk2 activity in response to ionizing radiation in oral squamous cell carcinoma cells.
    Yutori H; Semba S; Komori T; Yokozaki H
    Cancer Sci; 2008 Mar; 99(3):524-30. PubMed ID: 18167129
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Loss of FHIT expression in gastric carcinoma.
    Baffa R; Veronese ML; Santoro R; Mandes B; Palazzo JP; Rugge M; Santoro E; Croce CM; Huebner K
    Cancer Res; 1998 Oct; 58(20):4708-14. PubMed ID: 9788626
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Do FHIT gene alterations play a role in human solid tumors?
    Silveira Zavalhia L; Weber Medeiros A; Oliveira Silva A; Vial Roehe A
    Asia Pac J Clin Oncol; 2018 Oct; 14(5):e214-e223. PubMed ID: 29516675
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fragile histidine triad gene and skin cancer.
    Zanesi N; Croce CM
    Eur J Dermatol; 2001; 11(5):401-4. PubMed ID: 11525944
    [TBL] [Abstract][Full Text] [Related]  

  • 33. FHITness and cancer.
    Druck T; Berk L; Huebner K
    Oncol Res; 1998; 10(7):341-5. PubMed ID: 10063967
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fhit, a tumor suppressor protein, induces autophagy via 14-3-3τ in non-small cell lung cancer cells.
    Lee TG; Jeong EH; Kim SY; Kim HR; Kim H; Kim CH
    Oncotarget; 2017 May; 8(19):31923-31937. PubMed ID: 28404875
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular analysis of the fragile histidine triad (FHIT) tumor suppressor gene in vesical tumors of cattle with chronic enzootic hematuria (CEH).
    Guidi E; Uboldi C; Ferretti L
    Cytogenet Genome Res; 2008; 120(1-2):173-7. PubMed ID: 18467844
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of FRA16D/WWOX and FRA3B/FHIT genes in hematopoietic malignancies.
    Ishii H; Vecchione A; Furukawa Y; Sutheesophon K; Han SY; Druck T; Kuroki T; Trapasso F; Nishimura M; Saito Y; Ozawa K; Croce CM; Huebner K; Furukawa Y
    Mol Cancer Res; 2003 Nov; 1(13):940-7. PubMed ID: 14638866
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reduced Fhit expression occurs in the early stage of esophageal tumorigenesis: no correlation with p53 expression and apoptosis.
    Kitamura A; Yashima K; Okamoto E; Andachi H; Hosoda A; Kishimoto Y; Shiota G; Ito H; Kaibara N; Kawasaki H
    Oncology; 2001; 61(3):205-11. PubMed ID: 11574776
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Loss of fragile histidine triad gene expression in advanced lung cancer is consequent to allelic loss at 3p14 locus and promoter methylation.
    Wali A; Srinivasan R; Shabnam MS; Majumdar S; Joshi K; Behera D
    Mol Cancer Res; 2006 Feb; 4(2):93-9. PubMed ID: 16513840
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fhit modulates the DNA damage checkpoint response.
    Ishii H; Mimori K; Inoue H; Inageta T; Ishikawa K; Semba S; Druck T; Trapasso F; Tani K; Vecchione A; Croce CM; Mori M; Huebner K
    Cancer Res; 2006 Dec; 66(23):11287-92. PubMed ID: 17145874
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Altered expression of Fhit in carcinoma and precarcinomatous lesions of the esophagus.
    Mori M; Mimori K; Shiraishi T; Alder H; Inoue H; Tanaka Y; Sugimachi K; Huebner K; Croce CM
    Cancer Res; 2000 Mar; 60(5):1177-82. PubMed ID: 10728669
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.